Exceptional Response to AKT Inhibition in Patients With Breast Cancer and Germline PTEN Mutations.
Kingston B, Bailleux C, Delaloge S, Schiavon G, Scott V, Lacroix-Triki M, Carr TH, Kozarewa I, Gevensleben H, Kemp Z, Pearson A, Turner N, André F.
Kingston B, et al. Among authors: bailleux c.
JCO Precis Oncol. 2019 Dec 5;3:PO.19.00130. doi: 10.1200/PO.19.00130. eCollection 2019.
JCO Precis Oncol. 2019.
PMID: 32923864
Free PMC article.
No abstract available.